Cardiovascular side effects of newer antidepressants

Antony Fernandez, Suji E. Bang, Komandoor Srivathsan, W. Victor R. Vieweg

Research output: Contribution to journalReview article

19 Citations (Scopus)

Abstract

We review the cardiovascular effects of newer antidepressants. Although further studies are warranted, the safety of the selective serotonin reuptake inhibitors and the serotonin norepinephrine reuptake inhibitors on patients with comorbid cardiac conditions is impressive. Newer antidepressants should be considered as first-line agents for the treatment of depression in patients with and without cardiovascular disease.

Original languageEnglish (US)
Pages (from-to)305-309
Number of pages5
JournalAnadolu Kardiyoloji Dergisi
Volume7
Issue number3
StatePublished - Sep 1 2007

Fingerprint

Antidepressive Agents
Serotonin Uptake Inhibitors
Cardiovascular Diseases
Safety
Therapeutics
Serotonin and Noradrenaline Reuptake Inhibitors

Keywords

  • Antidepressant drugs
  • Atrial fibrillation
  • Blood pressure
  • Bradycardia
  • Cardiac death
  • Cardiovascular eftects
  • Electrocardiogram
  • Hypertension
  • Hypotension
  • QT interval
  • Tachycardia
  • Ventricular premature beats

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Fernandez, A., Bang, S. E., Srivathsan, K., & Vieweg, W. V. R. (2007). Cardiovascular side effects of newer antidepressants. Anadolu Kardiyoloji Dergisi, 7(3), 305-309.

Cardiovascular side effects of newer antidepressants. / Fernandez, Antony; Bang, Suji E.; Srivathsan, Komandoor; Vieweg, W. Victor R.

In: Anadolu Kardiyoloji Dergisi, Vol. 7, No. 3, 01.09.2007, p. 305-309.

Research output: Contribution to journalReview article

Fernandez, A, Bang, SE, Srivathsan, K & Vieweg, WVR 2007, 'Cardiovascular side effects of newer antidepressants', Anadolu Kardiyoloji Dergisi, vol. 7, no. 3, pp. 305-309.
Fernandez A, Bang SE, Srivathsan K, Vieweg WVR. Cardiovascular side effects of newer antidepressants. Anadolu Kardiyoloji Dergisi. 2007 Sep 1;7(3):305-309.
Fernandez, Antony ; Bang, Suji E. ; Srivathsan, Komandoor ; Vieweg, W. Victor R. / Cardiovascular side effects of newer antidepressants. In: Anadolu Kardiyoloji Dergisi. 2007 ; Vol. 7, No. 3. pp. 305-309.
@article{72ad92bcdc9d4ed18c9170412533abde,
title = "Cardiovascular side effects of newer antidepressants",
abstract = "We review the cardiovascular effects of newer antidepressants. Although further studies are warranted, the safety of the selective serotonin reuptake inhibitors and the serotonin norepinephrine reuptake inhibitors on patients with comorbid cardiac conditions is impressive. Newer antidepressants should be considered as first-line agents for the treatment of depression in patients with and without cardiovascular disease.",
keywords = "Antidepressant drugs, Atrial fibrillation, Blood pressure, Bradycardia, Cardiac death, Cardiovascular eftects, Electrocardiogram, Hypertension, Hypotension, QT interval, Tachycardia, Ventricular premature beats",
author = "Antony Fernandez and Bang, {Suji E.} and Komandoor Srivathsan and Vieweg, {W. Victor R.}",
year = "2007",
month = "9",
day = "1",
language = "English (US)",
volume = "7",
pages = "305--309",
journal = "Anatolian journal of cardiology",
issn = "2149-2263",
publisher = "Aves",
number = "3",

}

TY - JOUR

T1 - Cardiovascular side effects of newer antidepressants

AU - Fernandez, Antony

AU - Bang, Suji E.

AU - Srivathsan, Komandoor

AU - Vieweg, W. Victor R.

PY - 2007/9/1

Y1 - 2007/9/1

N2 - We review the cardiovascular effects of newer antidepressants. Although further studies are warranted, the safety of the selective serotonin reuptake inhibitors and the serotonin norepinephrine reuptake inhibitors on patients with comorbid cardiac conditions is impressive. Newer antidepressants should be considered as first-line agents for the treatment of depression in patients with and without cardiovascular disease.

AB - We review the cardiovascular effects of newer antidepressants. Although further studies are warranted, the safety of the selective serotonin reuptake inhibitors and the serotonin norepinephrine reuptake inhibitors on patients with comorbid cardiac conditions is impressive. Newer antidepressants should be considered as first-line agents for the treatment of depression in patients with and without cardiovascular disease.

KW - Antidepressant drugs

KW - Atrial fibrillation

KW - Blood pressure

KW - Bradycardia

KW - Cardiac death

KW - Cardiovascular eftects

KW - Electrocardiogram

KW - Hypertension

KW - Hypotension

KW - QT interval

KW - Tachycardia

KW - Ventricular premature beats

UR - http://www.scopus.com/inward/record.url?scp=34648840488&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34648840488&partnerID=8YFLogxK

M3 - Review article

C2 - 17785222

AN - SCOPUS:34648840488

VL - 7

SP - 305

EP - 309

JO - Anatolian journal of cardiology

JF - Anatolian journal of cardiology

SN - 2149-2263

IS - 3

ER -